|
Notice of M100-S15 (M7) Table 3A Erratum
We have identified the following error in document M100-S15 (M7), MIC Testing Supplemental Tables.
In Table 3A, Acceptable Limits for Quality Control Strains Used to Monitor Accuracy of Minimal Inhibitory Concentrations (MICs) (mg/mL) of Fastidious Organisms (page 142), the MIC ranges for Haemophilus influenzae ATCC® 49247 were misaligned, beginning with erythromycin. Correct ranges are as follows:
|
Antimicrobial Agent |
Haemophilus influenzae
ATCC® 49247 a |
|
Erythromycin |
– |
|
Fleroxacin |
0.03–0.12 |
|
Garenoxacin |
0.002-0.008 |
|
Gatifloxacin |
0.004–0.03 |
|
Gemifloxacin |
0.002–0.008 |
|
Gentamicin |
– |
|
Grepafloxacin |
0.002–0.015 |
|
Imipenem |
– |
|
Levofloxacin |
0.008–0.03 |
|
Linezolid |
– |
|
Lomefloxacin |
0.03–0.12 |
|
Loracarbef |
– |
|
Meropenem |
– |
|
Metronidazole |
– |
|
Moxifloxacin |
0.008–0.03 |
|
Nitrofurantoin |
– |
If you have not received a corrective label (for purchasers of paper documents) or a corrected PDF file (for purchasers of electronic documents) by 15 February 2005, please contact Linda Charles (extension 115) or Sheryl Wildgust (extension 130) at the Executive Offices +610.688.0100.
Thank you for your assistance. We regret any inconvenience.
[
return to top ]
|
